Indegene Ltd.

₹581.1

Indegene Ltd.

₹581.1

₹581.1

-11.95 (-2.02%) - 17 Jun 2025 04:18 PM

About Company

Indegene provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its solutions enable life sciences companies to develop products, launch them in the market, and drive sales through their life cycle in a more effective, efficient and modern manner. It achieves this by combining over two decades of healthcare domain expertise and fit-for purpose technology. 

Market Cap. ₹ 14,237 Cr.
52 Week - High/Low ₹ 736/499
P/E Ratio 78.24
P/B Ratio 7.54
Enterprise Value ₹ 14,124 Cr.
ROE % 13.07
RSI Value -
EMA 50 584.31
EMA 200 589.33
Market Cap. ₹ 14,237 Cr.
52 Week - High/Low ₹ 736/499
P/E Ratio 34.89
P/B Ratio 5.44
Enterprise Value ₹ 13,919 Cr.
ROE % 20.45
RSI Value -
EMA 50 584.31
EMA 200 589.33

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.